Phexxi - (1.8% /1% /0.4% ; Vaginal Gel)

Generic Name	Lactic Acid, Citric Acid and Potassium Bitartrate	Innovator	Evofem Biosciences
Dosage	1.8% /1% /0.4% ; Vaginal Gel	Branded US Sales	Less Than $1000 mn
Probable FTF	Less Than 5	Known Para IV Filers	Less Than 5
Other ANDA developers	Less Than 5	Tentative Approvals	None
Final Approvals	None	Generic Launches	None
Indication	PHEXXI is a combination of lactic acid, citric acid, and potassium bitartrate indicated for the prevention of pregnancy in females of reproductive potential for use as an on-demand method of contraception.
Complexities	Yes

Executive Summary

Patent Status

Launch Timelines and Competition

Company	FTF Status / 180 days exclusivity	30-Months stay	Current Litigation Status	Current Approval Status	Likelihood of launch
*******	*** \ *********	*** **, ****	******* ***** ********** ** **** ***	****	** *** **, ****

Chronology Of Events